5877 related articles for article (PubMed ID: 2477904)
21. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
22. [Possibilities and limits of the use of interferons in the clinic].
Ludwig CU
Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
[TBL] [Abstract][Full Text] [Related]
23. Update on the antitumor activity of alpha interferon.
Quesda JR
Oncology (Williston Park); 1988 Mar; 2(3):49-54. PubMed ID: 3079324
[TBL] [Abstract][Full Text] [Related]
24. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
25. Biologic therapy in patients receiving salvage treatment.
Bukowski RM
Semin Oncol; 1994 Aug; 21(4 Suppl 7):96-9. PubMed ID: 8091247
[TBL] [Abstract][Full Text] [Related]
26. [The role of biotherapy in multiple myeloma].
Petrucci MT; Tafuri A; Mandelli F
Recenti Prog Med; 2000 Oct; 91(10):488-93. PubMed ID: 11072735
[TBL] [Abstract][Full Text] [Related]
27. Cytokines in the treatment of hematological disorders: recent progress and perspectives.
Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(1):5-9. PubMed ID: 8874763
[TBL] [Abstract][Full Text] [Related]
28. Biological response modifiers in cancer therapy.
Gupta S; Kanodia AK
Natl Med J India; 2002; 15(4):202-7. PubMed ID: 12296474
[TBL] [Abstract][Full Text] [Related]
29. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
30. The alpha interferons: clinical overview.
Spiegel RJ
Semin Oncol; 1987 Jun; 14(2 Suppl 2):1-12. PubMed ID: 3296210
[TBL] [Abstract][Full Text] [Related]
31. Interferon therapy in cancer: from imaginon to interferon.
Goldstein D; Laszlo J
Cancer Res; 1986 Sep; 46(9):4315-29. PubMed ID: 2425950
[No Abstract] [Full Text] [Related]
32. [Interferons, interleukin-2 and tumor necrosis factor. New approaches to cancer therapy].
Oettgen HF
Arzneimittelforschung; 1987 Feb; 37(2A):251-5. PubMed ID: 2436634
[TBL] [Abstract][Full Text] [Related]
33. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):67-82. PubMed ID: 9044511
[TBL] [Abstract][Full Text] [Related]
35. [Interferon in the treatment of solid tumors].
Lukac J; Seso D; Daković N; Ferencić Z; Cajkovac V; Belicza M; Soos E; Ikić D; Kusić Z
Lijec Vjesn; 1994; 116(11-12):303-7. PubMed ID: 7536287
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
37. Clinical use of biologic response modifiers in cancer treatment: an overview. Part I. The interferons.
Balmer CM
DICP; 1990; 24(7-8):761-8. PubMed ID: 1695795
[TBL] [Abstract][Full Text] [Related]
38. [High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review].
Mosthaf FA; Hanhoff NJ; Goetzenich A; Wolf E; Knechten H
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1849-52. PubMed ID: 16915544
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
40. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
